RetroSense Therapeutics Granted Patent on Proprietary Method for Restoring Vision using Optogenetics
RetroSense Therapeutics Secures Exclusive Worldwide Rights to ReaChR Optogene from the University of California San Diego
Past performance is not indicative of future results. There is neither representation nor warranty as to the current accuracy or, nor liability for, decisions based on such information. This article is distributed for informational purposes only and should not be considered as investment advice, a ...
Confused by financial industry jargon? We're here to help.